# gene (news sources) — RSS Amplifier Recent posts from the 5 feeds in the RSS Amplifier directory that cover gene. Page: Feed: --- ## [Lawmakers urge FDA to enact new China policies after 3 gene therapy deaths](https://www.biospace.com/policy/lawmakers-urge-fda-to-enact-new-china-policies-after-3-gene-therapy-deaths) _2026-08-21 · Gabrielle Masson · All News_ Three fatalities occurring recently in China clinical trials have spurred two members of U.S. Congress to urge the FDA to enact new policies designed to protect American patients. ## [Werewolf and Ambros to tie the knot in $150M rare disease deal](https://www.biospace.com/deals/werewolf-and-ambros-to-tie-the-knot-in-150m-rare-disease-deal) _2026-08-21 · Michael Gibney · All News_ The merger, which would create a new company bearing Ambros’ name, will help support development of Ambros' non-opioid painkiller for patients with debilitating limb injuries. ## [Novo Nordisk starts trialing lower maintenance doses of oral Wegovy](https://www.biospace.com/drug-development/novo-nordisk-starts-trialing-lower-maintenance-doses-of-oral-wegovy) _2026-08-21 · Nick Paul Taylor · All News_ The Phase 3 study is evaluating two doses of Novo’s Wegovy pill in people with obesity or overweight in combination with a reduced-calorie diet and increased physical activity. ## [Roche commits $750m to double Oregon-based US manufacturing capacity](https://www.pharmaceutical-technology.com/news/roche-750m-oregon-us-injectable-manufacturing-site/) _2026-08-21 · Annabel Kartal Allen · Pharmaceutical Technology_ Roche's Oregon fill-finish site will produce both autoinjectors and pre-filled syringes – serving its pipeline and portfolio. ## [Eli Lilly’s weekly insulin jab Onswik set for NHS use if approved](https://www.pharmaceutical-technology.com/news/eli-lillys-weekly-insulin-jab-onswik-set-for-nhs-use-if-approved/) _2026-08-21 · Robert Barrie · Pharmaceutical Technology_ Lilly’s drug could cut the number of injections each patient needs by 85%. ## [WellSpan and Johns Hopkins renew partnership for advanced cancer care access](https://www.pharmaceutical-technology.com/news/wellspan-johns-hopkins-advanced-cancer-care/) _2026-08-21 · Salong Debbarma · Pharmaceutical Technology_ WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration to widen access to advanced care throughout central Pennsylvania, US. ## [Charles River and MVC to develop enterovirus vaccine](https://www.pharmaceutical-technology.com/news/charles-river-mvc-enterovirus-vaccine/) _2026-08-21 · Salong Debbarma · Pharmaceutical Technology_ Charles River Laboratories International and MVC have entered a collaboration to support the characterisation, along with validation of the virus seed bank for the latter’s next-generation multivalent enterovirus vaccine. ## [Roche pours $750M into Oregon manufacturing plant as obesity push expands](https://www.biospace.com/drug-delivery/roche-pours-750m-into-oregon-manufacturing-plant-as-obesity-push-expands) _2026-08-20 · Gabrielle Masson · All News_ After committing $2 billion to a new North Carolina facility to boost capacity for its next-gen obesity candidates, Roche's Genentech is putting down more cash to expand a device fill-finish site in Oregon. ## [Scribe’s early-stage IPO standout defies biotech’s derisking trend](https://www.biospace.com/business/scribes-early-stage-ipo-standout-defies-biotechs-derisking-trend) _2026-08-20 · Gabrielle Masson · All News_ Scribe Therapeutics’ one-time epigenetic treatment is designed to slash the adherence burden of chronic cholesterol-lowering therapies while sidestepping the irreversibility of gene editing. ## [Regeneron wins FDA approval to challenge Ipsen for rare bone disease market](https://www.biospace.com/fda/regeneron-wins-fda-approval-to-challenge-ipsen-for-rare-bone-disease-market) _2026-08-20 · Nick Paul Taylor · All News_ Regeneron’s Pasatru is the second fibrodysplasia ossificans progressiva drug approved in the U.S., following the 2023 approval of Ipsen’s Sohonos. ## [Unlimited Mobile Internet, One V-SIM (Sponsored)](https://crawlproof.com/a/idCRROUSDRvw) _2026-08-20 · **Sponsored**_ Automatically switches across T-Mobile, AT&T and Verizon; no throttling, no contract. ## [Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision](https://www.biospace.com/fda/ultragenyx-bags-first-gene-therapy-approval-as-previously-rejected-sanfilippo-asset-awaits-decision) _2026-08-20 · Nick Paul Taylor · All News_ The accelerated greenlight for Ultragenyx’s gene therapy for glycogen storage disease has raised analyst expectations for approval of UX111, which the FDA rejected last summer and is currently reviewing for a second time. A decision is expected by mid-September. ## [Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future](https://www.biospace.com/business/mercks-moderna-partnered-vaccine-success-clears-view-of-post-keytruda-future) _2026-08-20 · Annalee Armstrong · All News_ Investors had been pessimistic about the probability of success for the personalized cancer vaccine intismeran autogene, so the Phase 3 win was a welcome surprise. ## [Rewriting the rules of CMV prevention](https://www.biospace.com/drug-development/rewriting-the-rules-of-cmv-prevention) _2026-08-20 · Jennifer C. Smith-Parker · All News_ In this episode of Denatured, you’ll hear from Ian McGowan, Chief Medical Officer at Synklino and James Hunter, associate professor of transplantation at Oxford University. We explore transplantation and antiviral innovation and why CMV remains one of the most persistent and consequential challenges facing transplant patients today. ## [Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’](https://www.pharmaceutical-technology.com/news/regenerons-pasatru-wins-fda-approval-in-ultra-rare-stone-man-disease/) _2026-08-20 · Robert Barrie · Pharmaceutical Technology_ Pasatru demonstrated strong efficacy in a Phase III trial, helping patients reduce lesions and flare-ups. ## [Kynexis pockets €97m to advance cognition-focused schizophrenia drug](https://www.pharmaceutical-technology.com/news/kynexis-97m-cognitive-focused-schizophrenia-drug-progression/) _2026-08-20 · Annabel Kartal Allen · Pharmaceutical Technology_ Kynexis will now prepare for registrational studies on lead asset, KYN-5356 in cognitive impairment associated with schizophrenia (CIAS). ## [FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy](https://www.pharmaceutical-technology.com/news/fda-approval-ultragenyx-genglycos-gene-therapy/) _2026-08-20 · Salong Debbarma · Pharmaceutical Technology_ Ultragenyx Pharmaceutical has received accelerated approval from the FDA for its gene therapy, Genglycos, to treat GSDIa. ## [SandboxAQ introduces AQPotency for virtual drug screening](https://www.pharmaceutical-technology.com/news/sandboxaq-aqpotency-virtual-drug-screening/) _2026-08-20 · Salong Debbarma · Pharmaceutical Technology_ SandboxAQ has introduced AQPotency, a LQM designed to virtually screen and predict the potential of drug candidates without the need for a solved protein structure. ## [7 biopharma M&A deals where layoffs followed](https://www.biospace.com/job-trends/7-biopharma-m-a-deals-where-layoffs-followed) _2026-08-20 · Angela Gabriel · All News_ Workforce cuts this year at seven companies involved in recent mergers and acquisitions will cost over 1,300 employees their jobs. Affected businesses include Arcellx and Tourmaline Bio, acquired by Gilead Sciences and Novartis, respectively. ## [Out of sight, out of work? What’s driving remote job cuts](https://www.biospace.com/job-trends/out-of-sight-out-of-work-whats-driving-remote-job-cuts) _2026-08-20 · Angela Gabriel · All News_ Biopharma professionals sometimes find themselves out of jobs when employers want to bring staff back into the office, as recently seen at biotech EMD Serono and Exelixis. ## [Why pediatric rare oncology outperforms in a volatile biotech market](https://www.biospace.com/drug-development/opinion-why-pediatric-rare-oncology-outperforms-in-a-volatile-biotech-market) _2026-08-20 · Paul Romness · All News_ Real progress happens where unmet medical need is greatest and patient impact can be clearly measured. Pediatric rare cancers exemplify these criteria and have therefore generated continued investment, even in a capital-constrained environment. ## [Generate Viral Hot Takes (Sponsored)](https://crawlproof.com/a/B8pCn1riAwgR) _2026-08-20 · **Sponsored**_ Get platform-optimized hot takes and rebuttals to spark debate and engagement ## [Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analysts](https://www.biospace.com/fda/trumps-fda-pick-overton-good-for-psychedelics-new-pain-meds-but-bad-for-vaccines-analysts) _2026-08-19 · Heather McKenzie · All News_ If confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA commissioner—is expected to be a boon for developers of psychedelic therapeutics and non-opioid pain drugs, but could tow the party line on vaccines. ## [BioMarin spends up to $490m for Alesta’s bone disease candidate](https://www.pharmaceutical-technology.com/news/biomarin-spends-up-to-490m-for-alestas-bone-disease-candidate/) _2026-08-19 · Robert Barrie · Pharmaceutical Technology_ The deal provides BioMarin with a potential rival to AstraZeneca’s blockbuster Strensiq in hypophosphatasia. ## [Kolon TissueGene cuts 37 US staffers after Phase 3 fail](https://www.biospace.com/biospace-layoff-tracker) _2026-08-19 · BioSpace Editorial Staff · Biopharma Business News_ Follow along as BioSpace tracks job cuts and restructuring initiatives. ## [Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goal](https://www.biospace.com/drug-development/moderna-stock-nearly-doubles-as-merck-partnered-mrna-cancer-vaccine-meets-phase-3-goal) _2026-08-19 · Nick Paul Taylor · Drug Development News_ Melanoma was slower to recur in patients receiving Merck and Moderna's mRNA vaccine with Keytruda, supporting use of the combination in adjuvant treatment. The partners plan to take the data to the FDA. ## [Enveda’s exercise-simulating obesity tablet clears early clinical test](https://www.biospace.com/drug-development/envedas-exercise-simulating-obesity-tablet-clears-early-clinical-test) _2026-08-19 · Nick Paul Taylor · Drug Development News_ Touting an “exceptional” gastrointestinal safety profile for its oral obesity drug candidate in a study of healthy volunteers, Enveda plans to test the asset in people stopping GLP-1 treatment. ## [2026 IPO stock tracker: How newly public biotechs are performing](https://www.biospace.com/business/2026-ipo-stock-tracker-how-biotechs-new-to-public-markets-are-performing) _2026-08-19 · Gabrielle Masson · Biopharma Business News_ BioSpace is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026. ## [Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, more](https://www.biospace.com/fda/amylyxs-redemption-story-summits-survival-woes-definiums-anxiety-win-more) _2026-08-19 · Jef Akst · Biopharma Business News_ Amylyx shares good news for its investigational GLP-1 blocker; Definium announces positive data for its LSD-based therapy in anxiety; Summit/Akeso’s ivonescimab shows degrading survival benefits; patients treated with Neurocrine’s Prader-Willi drug experience serious adverse events; and Eli Lilly cracks down on the black market for next-gen obesity asset retatrutide. ## [Trump expected to nominate Heidi Overton as new FDA commissioner](https://www.pharmaceutical-technology.com/news/trump-nominates-heidi-overton-fda-commissioner/) _2026-08-19 · Annabel Kartal Allen · Pharmaceutical Technology_ Overton could take the helm at the FDA during a tumultuous period for the agency, defined by several resignations, firings and redundancies. ## [Andelyn Biosciences to develop GM2 gangliosidosis therapy](https://www.pharmaceutical-technology.com/news/andelyn-to-develop-gm2-gangliosidosis-therapy/) _2026-08-19 · Salong Debbarma · Pharmaceutical Technology_ Andelyn Biosciences is set to develop and manufacture a gene therapy known as AAV9-GM2, for Queen’s University to treat GM2 gangliosidoses, including Tay-Sachs and Sandhoff diseases. ## [BeOne Medicines and partners renew Brukinsa access programme for CLL](https://www.pharmaceutical-technology.com/news/beone-medicines-partners-renew-brukinsa-programme/) _2026-08-19 · Salong Debbarma · Pharmaceutical Technology_ BeOne Medicines, the BeOne Care Foundation, and The Max Foundation have extended their Brukinsa access programme for CLL until 2028. ## [Persona-led AI publishing (Sponsored)](https://crawlproof.com/a/zL4Jn9oYeMWJ) _2026-08-19 · **Sponsored**_ Generate drafts, schedule subdomain publishing, and keep human review where needed. ## [Reformed pharmaceutical regulation across India’s drug landscape](https://www.pharmaceutical-technology.com/analyst-comment/reformed-pharmaceutical-regulation-across-india-drug-landscape/) _2026-08-18 · GlobalData Healthcare · Pharmaceutical Technology_ One of the major changes made to India’s primary legal framework for drug price regulation affects the pricing of essential drugs. ## [Updated UK guidance for finerenone introduces new treatment for HF patients](https://www.pharmaceutical-technology.com/analyst-comment/updated-uk-guidance-finerenone-hf/) _2026-08-18 · GlobalData Healthcare · Pharmaceutical Technology_ New guidance from NICE provide a framework for UK care providers using finerenone to manage the treatment of certain types of heart failure. ## [Donor limits and genetic risk: Separating fact from perception](https://www.progress.org.uk/donor-limits-and-genetic-risk-separating-fact-from-perception/) _2026-08-17 · Dr Heidi Mertes and 1 others · PET_ Limits on the number of children born from one donor may have ethical and psychosocial benefits, but they will not reduce the overall likelihood of donor-conceived people inheriting genetic conditions, write Dr Heidi Mertes and Dorian Accoe... ## [Stem-cell-based embryo models: Regulating for the future](https://www.progress.org.uk/stem-cell-based-embryo-models-regulating-for-the-future/) _2026-08-17 · BioNews · PET_ ## [Why limits to gamete donor use only work if they cross borders](https://www.progress.org.uk/why-limits-to-gamete-donor-use-only-work-if-they-cross-borders/) _2026-08-17 · Professor Lucy Frith and 1 others · PET_ A recent paper calls on the European Union to introduce an EU-wide limit on families created from a single donor's sperm. Professors Lucy Frith and Jackson Kirkman-Brown explain why... ## [CHEK2 gene variant and breast cancer risk](https://www.progress.org.uk/chek2-gene-variant-and-breast-cancer-risk/) _2026-08-17 · BioNews · PET_ ## [Another US doctor sued for using own sperm to inseminate patients](https://www.progress.org.uk/another-us-doctor-sued-for-using-own-sperm-to-inseminate-patients/) _2026-08-17 · BioNews · PET_ ## [Podcast Review: The Gift – Twins](https://www.progress.org.uk/podcast-review-the-gift-twins/) _2026-08-17 · Varsha Traynor · PET_ An at-home DNA test reveals an astonishing truth: twins Michelle and Lavinia have different biological fathers. Varsha Traynor reviews BBC Radio 4's The Gift – Twins, a moving exploration of family, identity and genetic testing… ## [Rare gene variants linked to better body fat distribution and metabolic health](https://www.progress.org.uk/rare-gene-variants-linked-to-better-body-fat-distribution-and-metabolic-health/) _2026-08-17 · Dr Teja Rus · PET_ Rare variants in the FNIP1 gene are linked to lower body fat, less liver fat, a more favourable fat distribution and around 60 percent lower odds of cardiometabolic disease, according to the largest exome-sequencing study of energy metabolism to date... ## [Stem cell research shows vape flavour could affect embryo development](https://www.progress.org.uk/stem-cell-research-shows-vape-flavour-could-affect-embryo-development/) _2026-08-17 · Martha Simmonds · PET_ Vanillin, a common flavouring used in vapes and e-cigarettes, may pose a risk to embryonic development if inhaled during pregnancy..... ## [Human genome benchmark maps both sets of chromosomes to fill gaps in genetic data](https://www.progress.org.uk/human-genome-benchmark-maps-both-sets-of-chromosomes-to-fill-gaps-in-genetic-data/) _2026-08-17 · Grace Woolston · PET_ Scientists have obtained the most complete and accurate sequence of a human diploid reference genome to date, paving the way for advancements in personalised medicine... ## [US Congresswoman documents freezing her eggs](https://www.progress.org.uk/us-congresswoman-documents-freezing-her-eggs/) _2026-08-17 · Dr Rachel Montgomery · PET_ US Congresswoman Alexandria Ocasio-Cortez has announced that she is undergoing egg freezing and is sharing details of the process on social media...